Request for applications: islet cell replacement in type 1 diabetes.
The American Diabetes Association announces funding for clinical and basic science studies in three major areas of research that focus on cell-based insulin replacement in type 1 diabetes: 1. Genetic engineering of nonpancreatic cells into glucose-sensitive insulin-producing cells; 2. Transforming stem cells, pancreatic ductal cells, or pancreatic endocrine cell lines into glucose-sensitive insulin-producing cells; and 3. Xenografts of nonhuman islet cells.
Campbell
Scott
S
American Diabetes Association, Research Programs, Alexandria, VA, USA. scampbell@diabetes.org
D000818:Animals; D002460:Cell Line; D017690:Cell Transplantation; D002478:Cells, Cultured; D003922:Diabetes Mellitus, Type 1 / Q000601:surgery / Q000628:therapy*; D005818:Genetic Engineering; D006801:Humans; D007328:Insulin / Q000378:metabolism; D007515:Islets of Langerhans / Q000378:metabolism*; D016381:Islets of Langerhans Transplantation / Q000379:methods*; D010179:Pancreas / Q000166:cytology; D010183:Pancreatic Ducts / Q000166:cytology; D014183:Transplantation, Heterologous
D007328:Insulin